What is CNS Pharmaceuticals, Inc. Common Stock's Market Cap?

CNS Pharmaceuticals, Inc. Common Stock's Market Cap is $7.3M, based on as-reported figures from SEC (XBRL) filings.

What is CNS Pharmaceuticals, Inc. Common Stock's Enterprise Value?

CNS Pharmaceuticals, Inc. Common Stock's Enterprise Value is -$12.7M, based on as-reported figures from SEC (XBRL) filings.

What is CNS Pharmaceuticals, Inc. Common Stock's EV / EBITDA?

CNS Pharmaceuticals, Inc. Common Stock's EV / EBITDA is 0.8×, based on as-reported figures from SEC (XBRL) filings.

What is CNS Pharmaceuticals, Inc. Common Stock's Net Income (TTM)?

CNS Pharmaceuticals, Inc. Common Stock's Net Income (TTM) is -$16.7M, based on as-reported figures from SEC (XBRL) filings.

What is CNS Pharmaceuticals, Inc. Common Stock's EBITDA?

CNS Pharmaceuticals, Inc. Common Stock's EBITDA is -$16.9M, based on as-reported figures from SEC (XBRL) filings.

What is CNS Pharmaceuticals, Inc. Common Stock's Diluted EPS (TTM)?

CNS Pharmaceuticals, Inc. Common Stock's Diluted EPS (TTM) is -11.43, based on as-reported figures from SEC (XBRL) filings.

What is CNS Pharmaceuticals, Inc. Common Stock's Net Debt?

CNS Pharmaceuticals, Inc. Common Stock's Net Debt is -$20.0M, based on as-reported figures from SEC (XBRL) filings.

AKYLA/ Financials

Equity / PHARMACEUTICAL PREPARATIONS

CNS Pharmaceuticals, Inc. Common Stock

XNAS · usd

SIC 2834 · PHARMACEUTICAL PREPARATIONS

FIGI BBG00PM24TS7

4.97▲ 0.22 (4.63%)

As of 2026-10-23

Price / Volume

Valuation

Market Cap
Enterprise Value
Trailing P/E: —
Price / Sales: —
EV / Revenue: —
EV / EBITDA

Financial Highlights

Revenue (TTM): —
Net Income (TTM)
EBITDA
Diluted EPS (TTM)
EBITDA Margin: —
Net Debt

Trading Information

Previous Close: 4.75
Day's Range: 3.67 – 5.00
52-Week Range: 1.88 – 10.54
Volume: 5,966
Avg Volume: 4,618

Share Statistics

Shares Outstanding
Employees: 8
Exchange: XNAS
Listed: 2019-11-08

Share count as of August 11, 2026

CNS Pharmaceuticals, Inc. Common Stock (CNSP) Financial Statements

View

Income Statement

Detail

Standard

Period

Quarterly

Loading Income Statement…

Key questions about CNS Pharmaceuticals, Inc. Common Stock (CNSP)

What is CNS Pharmaceuticals, Inc. Common Stock's Market Cap?: CNS Pharmaceuticals, Inc. Common Stock's Market Cap is $7.3M, based on as-reported figures from SEC (XBRL) filings.
What is CNS Pharmaceuticals, Inc. Common Stock's Enterprise Value?: CNS Pharmaceuticals, Inc. Common Stock's Enterprise Value is -$12.7M, based on as-reported figures from SEC (XBRL) filings.
What is CNS Pharmaceuticals, Inc. Common Stock's EV / EBITDA?: CNS Pharmaceuticals, Inc. Common Stock's EV / EBITDA is 0.8×, based on as-reported figures from SEC (XBRL) filings.
What is CNS Pharmaceuticals, Inc. Common Stock's Net Income (TTM)?: CNS Pharmaceuticals, Inc. Common Stock's Net Income (TTM) is -$16.7M, based on as-reported figures from SEC (XBRL) filings.
What is CNS Pharmaceuticals, Inc. Common Stock's EBITDA?: CNS Pharmaceuticals, Inc. Common Stock's EBITDA is -$16.9M, based on as-reported figures from SEC (XBRL) filings.
What is CNS Pharmaceuticals, Inc. Common Stock's Diluted EPS (TTM)?: CNS Pharmaceuticals, Inc. Common Stock's Diluted EPS (TTM) is -11.43, based on as-reported figures from SEC (XBRL) filings.
What is CNS Pharmaceuticals, Inc. Common Stock's Net Debt?: CNS Pharmaceuticals, Inc. Common Stock's Net Debt is -$20.0M, based on as-reported figures from SEC (XBRL) filings.

Akyla / Financials · CNSPAs-filed SEC (XBRL) data